Clinical Trial Update: rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors [Phase 4]

View source ↗

Summary

This entry provides a Phase 4 update on rAd-p53 gene therapy for advanced malignant thyroid tumors, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Drugs mentioned

• rAd-p53 gene therapy

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Advanced Malignant Thyroid Tumors | Phase 4 | Status: UNKNOWN